Aegicare Company

Aegicare develops gene intelligence algorithms for patients, medical institutions, scientific research institutions, and pharmaceutical companies. That provides sample management, bioinformatics analysis, a family map, and information retrieval. Aegicar uses genetic intelligence to diagnose rare diseases and develop drugs. Aegicar Aegicar develops gene intelligence algorithms for patients, medical institutions, scientific research institutions, and innovative pharmaceutical companies based on cutting-edge bioinformatics, medical genetics, high-throughput sequencing technology, functional genomics technology, artificial intelligence, and cloud computing technology to solve rare disease-related information mining, translation, interpretation, clinical decision-making assistance, and drug development.

Total Funding: 7800000
Founded Date: 2017-01-01
Industry: Quantum Biology
Employee Number: 51-100
Last Funding Date: 2019-06-14
Funding Status: private
Headquarters: Palo Alto,California,United States,North America
Super Industry: Quantum Science Applications
Funding Stage: Early Stage Venture
Funding Total Value: 7800000
Last Funding Total Usd: 4000000
Last Funding Total Currency: USD
Last Funding Total Value: 4000000
Founders: Jian Ma,Lv Peitao,Yang Li